| Name | Title | Contact Details |
|---|
Tobira Therapeutics is a clinical-stage biopharmaceutical company developing cenicriviroc (CVC), an oral potent dual inhibitor of chemokine receptors CCR2 and CCR5. Tobira is initiating a Phase 2 clinical trial of cenicriviroc for the treatment of Nonalcoholic Steatohepatitis (NASH), a leading cause of cirrhosis and liver transplant. The company has also completed a Phase 2b clinical trial of cenicriviroc in 143 HIV-infected subjects, and the compound is positioned for Phase 3 studies as a novel, once daily, fixed-dose cenicriviroc/lamivudine backbone as part of combination HIV therapy. Tobira is backed by a syndicate of leading life science investors including Domain Associates, Frazier Healthcare Ventures, Montreux Equity Partners, Novo Ventures and Canaan Partners.
Accupac has proven to be a leader in the contract manufacturing of a variety of medical devices. Our syringe technology is just one example. We have the capability to manufacture the product, fill, label and then seal the syringe into a thermoform tray
Cedarburg Hauser Pharmaceuticals is a Grafton, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Groups Recover Together offers medication-assisted treatment (MAT) for opioid addiction. We can prescribe Buprenorphine (Suboxone) medication you need today to stop feeling sick, and a supportive community you can rely on to help you to succeed.
Inclinix Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.